Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Extended interval BNT162b2 vaccination enhances peak antibody generation.
Parry H, Bruton R, Stephens C, Bentley C, Brown K, Amirthalingam G, Hallis B, Otter A, Zuo J, Moss P. Parry H, et al. Among authors: otter a. NPJ Vaccines. 2022 Jan 27;7(1):14. doi: 10.1038/s41541-022-00432-w. NPJ Vaccines. 2022. PMID: 35087066 Free PMC article.
Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021.
Whitaker HJ, Elgohari S, Rowe C, Otter AD, Brooks T, Linley E, Hayden I, Ribeiro S, Hewson J, Lakhani A, Clarke E, Tsang C, Campbell CN, Ramsay M, Brown K, Amirthalingam G. Whitaker HJ, et al. Among authors: otter ad. J Infect. 2021 Aug;83(2):237-279. doi: 10.1016/j.jinf.2021.04.037. Epub 2021 May 11. J Infect. 2021. PMID: 33989631 Free PMC article.
Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia.
Parry H, McIlroy G, Bruton R, Ali M, Stephens C, Damery S, Otter A, McSkeane T, Rolfe H, Faustini S, Wall N, Hillmen P, Pratt G, Paneesha S, Zuo J, Richter A, Moss P. Parry H, et al. Among authors: otter a. Blood Cancer J. 2021 Jul 30;11(7):136. doi: 10.1038/s41408-021-00528-x. Blood Cancer J. 2021. PMID: 34330895 Free PMC article. Clinical Trial.
Immunogenicity of single vaccination with BNT162b2 or ChAdOx1 nCoV-19 at 5-6 weeks post vaccine in participants aged 80 years or older: an exploratory analysis.
Parry H, Bruton R, Tut G, Ali M, Stephens C, Greenwood D, Faustini S, Hughes S, Huissoon A, Meade R, Brown K, Amirthalingam G, Otter A, Hallis B, Richter A, Zuo J, Moss P. Parry H, et al. Among authors: otter a. Lancet Healthy Longev. 2021 Sep;2(9):e554-e560. doi: 10.1016/S2666-7568(21)00169-0. Epub 2021 Aug 12. Lancet Healthy Longev. 2021. PMID: 34401865 Free PMC article.
mRNA vaccination in people over 80 years of age induces strong humoral immune responses against SARS-CoV-2 with cross neutralization of P.1 Brazilian variant.
Parry H, Tut G, Bruton R, Faustini S, Stephens C, Saunders P, Bentley C, Hilyard K, Brown K, Amirthalingam G, Charlton S, Leung S, Chiplin E, Coombes NS, Bewley KR, Penn EJ, Rowe C, Otter A, Watts R, D'Arcangelo S, Hallis B, Makin A, Richter A, Zuo J, Moss P. Parry H, et al. Among authors: otter a. Elife. 2021 Sep 29;10:e69375. doi: 10.7554/eLife.69375. Elife. 2021. PMID: 34586068 Free PMC article.
Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups.
Whitaker HJ, Tsang RSM, Byford R, Andrews NJ, Sherlock J, Sebastian Pillai P, Williams J, Button E, Campbell H, Sinnathamby M, Victor W, Anand S, Linley E, Hewson J, DArchangelo S, Otter AD, Ellis J, Hobbs RFD, Howsam G, Zambon M, Ramsay M, Brown KE, de Lusignan S, Amirthalingam G, Lopez Bernal J. Whitaker HJ, et al. J Infect. 2022 May;84(5):675-683. doi: 10.1016/j.jinf.2021.12.044. Epub 2022 Jan 3. J Infect. 2022. PMID: 34990709 Free PMC article.
Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia.
Parry H, McIlroy G, Bruton R, Damery S, Tyson G, Logan N, Davis C, Willett B, Zuo J, Ali M, Kaur M, Stephens C, Brant D, Otter A, McSkeane T, Rolfe H, Faustini S, Richter A, Lee S, Wandroo F, Shafeek S, Pratt G, Paneesha S, Moss P. Parry H, et al. Among authors: otter a. J Hematol Oncol. 2022 Jan 9;15(1):3. doi: 10.1186/s13045-021-01219-7. J Hematol Oncol. 2022. PMID: 35000597 Free PMC article.
Implementation and Extended Evaluation of the Euroimmun Anti-SARS-CoV-2 IgG Assay and Its Contribution to the United Kingdom's COVID-19 Public Health Response.
Otter AD, Bown A, D'Arcangelo S, Bailey D, Semper A, Hewson J, Catton M, Perumal P, Sweed A, McKee DF, Jones J, Harvala H, Lamikanra A, Zambon M, Andrews N, Whitaker H, Linley E, Mentzer AJ, Skelly D, Knight JC, Klenerman P; UKHSA Porton Euroimmun testing group; Amirthalingam G, Taylor S, Rowe C, Vipond R, Brooks T. Otter AD, et al. Microbiol Spectr. 2022 Feb 23;10(1):e0228921. doi: 10.1128/spectrum.02289-21. Epub 2022 Feb 23. Microbiol Spectr. 2022. PMID: 35196807 Free PMC article.
Sociodemographic disparities in COVID-19 seroprevalence across England in the Oxford RCGP primary care sentinel network.
Whitaker H, Tsang RSM, Button E, Andrews N, Byford R, Borrow R, Hobbs FDR, Brooks T, Howsam G, Brown K, Macartney J, Gower C, Okusi C, Hewson J, Sherlock J, Linley E, Tripathy M, Otter AD, Williams J, Tonge S, de Lusignan S, Amirthalingam G. Whitaker H, et al. J Infect. 2022 Jun;84(6):814-824. doi: 10.1016/j.jinf.2022.04.016. Epub 2022 Apr 9. J Infect. 2022. PMID: 35405169 Free PMC article.
155 results